ICAM2 and lymphangioma: Early progression of LM in the mice injected with LeptoM3 cells and treated with IgG control were detected in the third week after injection, whereas progression in the ICAM2 antibody-treated group was not detectable till the sixth week after injection (Fig. 6H).